161 related articles for article (PubMed ID: 2979038)
1. Gastric and duodenal ulcer in the same patient.
Battaglia G; Di Mario F; Cannizzaro R; Farinati R; Braghetto D; La Rosa G; Martin A; Naccarato R
Acta Gastroenterol Belg; 1988; 51(4-5):322-8. PubMed ID: 2979038
[TBL] [Abstract][Full Text] [Related]
2. [Primary peptic ulcer in childhood: apropos of 16 cases].
Carrasco S; Lama R; Polanco I; Alvarez-Coca J; Martínez García A; Fullana A; Vázquez C
An Esp Pediatr; 1987 Feb; 26(2):95-8. PubMed ID: 3565962
[TBL] [Abstract][Full Text] [Related]
3. Clinical relevance of Helicobacter pylori CagA-positive strains: gastroduodenal peptic lesions marker.
Martín Guerrero JM; Hergueta Delgado P; Esteban Carretero J; Romero Castro R; Pellicer Bautista FJ; Herrerías Gutiérrez JM
Rev Esp Enferm Dig; 2000 Mar; 92(3):160-73. PubMed ID: 10799946
[TBL] [Abstract][Full Text] [Related]
4. Serum pepsinogen I and pepsinogen II, and the ratio of pepsinogen I/pepsinogen II in peptic ulcer diseases: with special emphasis on the influence of the location of the ulcer crater.
Wu MS; Wang HP; Wang JT; Wang TH; Lin JT
J Gastroenterol Hepatol; 1995; 10(4):401-4. PubMed ID: 8527705
[TBL] [Abstract][Full Text] [Related]
5. Site of peptic ulcer. comparison of hydrochloric acid output, pepsinogen and gastrin serum levels.
Engler-Pinto Júnior P; Gama-Rodrigues J; Lopasso FP; Cordeiro AC; Saez-Alquezar A; Laudanna AA; Pinotti HW
Hepatogastroenterology; 1996; 43(12):1671-7. PubMed ID: 8975987
[TBL] [Abstract][Full Text] [Related]
6. Effect of age on gastric acid, pepsin, pepsinogen group A and gastrin secretion in peptic ulcer patients.
Pilotto A; Vianello F; Di Mario F; Plebani M; Farinati F; Azzini CF
Gerontology; 1994; 40(5):253-9. PubMed ID: 7959081
[TBL] [Abstract][Full Text] [Related]
7. Interaction of Helicobacter pylori infection and nonsteroidal anti-inflammatory drugs in gastric and duodenal ulcers.
Venerito M; Malfertheiner P
Helicobacter; 2010 Aug; 15(4):239-50. PubMed ID: 20633184
[TBL] [Abstract][Full Text] [Related]
8. Randomised clinical trial: efficacy and safety of vonoprazan vs. lansoprazole in patients with gastric or duodenal ulcers - results from two phase 3, non-inferiority randomised controlled trials.
Miwa H; Uedo N; Watari J; Mori Y; Sakurai Y; Takanami Y; Nishimura A; Tatsumi T; Sakaki N
Aliment Pharmacol Ther; 2017 Jan; 45(2):240-252. PubMed ID: 27891632
[TBL] [Abstract][Full Text] [Related]
9. Peptic ulceration and its correlation with symptoms.
Misiewicz JJ
Clin Gastroenterol; 1978 Sep; 7(3):571-82. PubMed ID: 361302
[TBL] [Abstract][Full Text] [Related]
10. [The characteristics of peptic ulcer in subjects with concomitant ischemic heart disease].
Loginov AS; Zvenigorodskaia LA; Potapova VB; Arbuzova VG; Korzhikov VV; Nilova TV
Ter Arkh; 1998; 70(2):9-13. PubMed ID: 9551561
[TBL] [Abstract][Full Text] [Related]
11. Th response to Helicobacter pylori differs between patients with gastric ulcer and duodenal ulcer.
Itoh T; Seno H; Kita T; Chiba T; Wakatsuki Y
Scand J Gastroenterol; 2005 Jun; 40(6):641-7. PubMed ID: 16036523
[TBL] [Abstract][Full Text] [Related]
12. The Helicobacter pylori duodenal ulcer promoting gene, dupA in China.
Zhang Z; Zheng Q; Chen X; Xiao S; Liu W; Lu H
BMC Gastroenterol; 2008 Oct; 8():49. PubMed ID: 18950522
[TBL] [Abstract][Full Text] [Related]
13. Long-term risk of gastric cancer by subsite in operated and unoperated patients hospitalized for peptic ulcer.
Bahmanyar S; Ye W; Dickman PW; Nyrén O
Am J Gastroenterol; 2007 Jun; 102(6):1185-91. PubMed ID: 17355418
[TBL] [Abstract][Full Text] [Related]
14. Serum group I pepsinogens by radioimmunoassay in control subjects and patients with peptic ulcer.
Samloff IM; Liebman WM; Panitch NM
Gastroenterology; 1975 Jul; 69(1):83-90. PubMed ID: 1150038
[TBL] [Abstract][Full Text] [Related]
15. Effect of programmed endoscopic follow-up examinations on the rebleeding rate of gastric or duodenal peptic ulcers treated by injection therapy: a prospective, randomized controlled trial.
Messmann H; Schaller P; Andus T; Lock G; Vogt W; Gross V; Zirngibl H; Wiedmann KH; Lingenfelser T; Bauch K; Leser HG; Schölmerich J; Holstege A
Endoscopy; 1998 Sep; 30(7):583-9. PubMed ID: 9826134
[TBL] [Abstract][Full Text] [Related]
16. Pepsinogen Group I radioimmunoassay and total serum pepsinogen colorimetric determination: a comparative study in normal subjects and in peptic ulcer patients.
Plebani M; Di Mario F; Vianello F; Giordano A; Masiero M; Lazzaretto M; Farini R; Ceriotti G; Naccarato R
Clin Biochem; 1983 Feb; 16(1):20-2. PubMed ID: 6861334
[TBL] [Abstract][Full Text] [Related]
17. Change in Prevalence and Pattern of Peptic Ulcer Disease in the Northern Savannah of Nigeria: An Endoscopic Study.
Yahya H
Ann Afr Med; 2023; 22(4):420-425. PubMed ID: 38358140
[TBL] [Abstract][Full Text] [Related]
18. Endoscopy in peptic diseases and bleeding: a community survey of 1635 patients.
Scobie BA
N Z Med J; 1988 Feb; 101(840):78-80. PubMed ID: 3380437
[TBL] [Abstract][Full Text] [Related]
19. Gastric cyto-secretory correlations in peptic ulcer.
Testino G; Cornaggia M; Valentini M
Hepatogastroenterology; 1999; 46(28):2710-2. PubMed ID: 10522069
[TBL] [Abstract][Full Text] [Related]
20. [Treatment of acute peptic gastroduodenal ulcer: omeprazole is superior to ranitidine especially in the early phase of ulcer healing. A prospective controlled randomized serial endoscopy study].
Hotz J; Kark W; Plein K; Wiedbrauck F; Guthke A; Otten O
Leber Magen Darm; 1995 Jul; 25(4):165-70. PubMed ID: 7564870
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
